Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors.

[1]  Y. Rojanasakul,et al.  Induction of TNFα in macrophages by vanadate is dependent on activation of transcription factor NF-κB and free radical reactions , 1999, Molecular and Cellular Biochemistry.

[2]  C. Sen.  Glutathione homeostasis in response to exercise training and nutritional supplements , 1999, Molecular and Cellular Biochemistry.

[3]  J. Haddad.  Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. , 2002, Cellular signalling.

[4]  J. Haddad.  Recombinant human interleukin (IL)-1 beta-mediated regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism. , 2002, European cytokine network.

[5]  J. Haddad.  Nuclear factor (NF)-κB blockade attenuates but does not abrogate LPS-mediated interleukin (IL)-1β biosynthesis in alveolar epithelial cells , 2002 .

[6]  J. Haddad,et al.  Nuclear factor-kappa B-independent regulation of lipopolysaccharide-mediated interleukin-6 biosynthesis. , 2002, Biochemical and biophysical research communications.

[7]  J. Haddad.  RECOMBINANT TNF-α MEDIATED REGULATION OF THE IκB-α/NF-κB SIGNALING PATHWAY: EVIDENCE FOR THE ENHANCEMENT OF PRO- AND ANTI-INFLAMMATORY CYTOKINES IN ALVEOLAR EPITHELIAL CELLS , 2002 .

[8]  J. Haddad,et al.  Redox regulation of TNF-α biosynthesis: Augmentation by irreversible inhibition of γ-glutamylcysteine synthetase and the involvement of an IκB-α/NF-κB-independent pathway in alveolar epithelial cells , 2002 .

[9]  N. Kernohan,et al.  Direct comparison of the nature of mouse and human GST T1-1 and the implications on dichloromethane carcinogenicity. , 2002, Toxicology and applied pharmacology.

[10]  Irfan Rahman,et al.  PM10-exposed macrophages stimulate a proinflammatory response in lung epithelial cells via TNF-α , 2002 .

[11]  J. Haddad,et al.  Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-kappaB/nuclear factor-kappaB-sensitive pathway in alveolar epithelial cells. , 2002, The Journal of pharmacology and experimental therapeutics.

[12]  J. Haddad,et al.  Redox signaling-mediated regulation of lipopolysaccharide-induced proinflammatory cytokine biosynthesis in alveolar epithelial cells. , 2002, Antioxidants & redox signaling.

[13]  J. Haddad,et al.  Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells. , 2002, The Journal of pharmacology and experimental therapeutics.

[14]  Yasushi Matsumura,et al.  Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002, Circulation.

[15]  J. Magdalou,et al.  Glucosamine modulates IL‐1‐induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF‐κB pathway , 2002, FEBS letters.

[16]  J. Haddad.  The involvement of L-gamma-glutamyl-L-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. , 2002, Biochemical pharmacology.

[17]  L. Tacchini,et al.  Activation of transcription factors by drugs inducing oxidative stress in rat liver. , 2002, Biochemical pharmacology.

[18]  I. Rahman,et al.  Glutathione and p53 independently mediate responses against oxidative stress in ES cells. , 2002, Free radical biology & medicine.

[19]  A. Harris,et al.  A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis , 2002, Oncogene.

[20]  J. Haddad,et al.  Redox/ROS regulation of lipopolysaccharide‐induced mitogen‐activated protein kinase (MAPK) activation and MAPK‐mediated TNF‐α biosynthesis , 2002, British journal of pharmacology.

[21]  C. Kretz-remy,et al.  Gene expression and thiol redox state. , 1999, Methods in enzymology.

[22]  J. Haddad,et al.  Amiloride Blockades Lipopolysaccharide-Induced Proinflammatory Cytokine Biosynthesis in an I κ B- α /NF- κ B–Dependent Mechanism: Evidence for the Amplification of an Antiinflammatory Pathway in the Alveolar Epithelium , 2002 .

[23]  J. Haddad,et al.  L-Buthionine-(S,R)-sulfoximine, an irreversible inhibitor of gamma-glutamylcysteine synthetase, augments LPS-mediated pro-inflammatory cytokine biosynthesis: evidence for the implication of an IkappaB-alpha/NF-kappaB insensitive pathway. , 2002, European cytokine network.

[24]  M. McMahon,et al.  Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. , 2001, Cancer letters.

[25]  H. Pinedo,et al.  Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1α Protein by the Oxidative Stressor Arsenite* , 2001, The Journal of Biological Chemistry.

[26]  N. Chandel,et al.  Reactive Oxygen Species Are Downstream Products of TRAF-mediated Signal Transduction* , 2001, The Journal of Biological Chemistry.

[27]  A. Siddiqui,et al.  Mitochondrially Associated Hepatitis B Virus X Protein Constitutively Activates Transcription Factors STAT-3 and NF-κB via Oxidative Stress , 2001, Molecular and Cellular Biology.

[28]  P. Murdock,et al.  Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. , 2001, The Biochemical journal.

[29]  G. Petrovics,et al.  Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38‐ and ERK‐MAP kinases and NF‐κB , 2001 .

[30]  M. Schindl,et al.  DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance. , 2001, International journal of oncology.

[31]  A. Stern,et al.  Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. , 2001, Annals of clinical and laboratory science.

[32]  J. Christman,et al.  Impaired Pulmonary NF-κB Activation in Response to Lipopolysaccharide in NADPH Oxidase-Deficient Mice , 2001, Infection and Immunity.

[33]  W. MacNee,et al.  Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear factor-kappaB. , 2001, Biochemical pharmacology.

[34]  J. Haddad,et al.  A non‐hypoxic, ROS‐sensitive pathway mediates TNF‐α‐dependent regulation of HIF‐1α , 2001 .

[35]  A. Harris,et al.  Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival , 2001, British Journal of Cancer.

[36]  B. Ahlemeyer,et al.  Preconditioning‐induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor‐κB , 2001, Journal of neurochemistry.

[37]  E. Zandi,et al.  Lipopolysaccharide Induces Rac1-dependent Reactive Oxygen Species Formation and Coordinates Tumor Necrosis Factor-α Secretion through IKK Regulation of NF-κB* , 2001, The Journal of Biological Chemistry.

[38]  S. Reddy,et al.  Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione. , 2001, American journal of respiratory cell and molecular biology.

[39]  J. Alam,et al.  Cobalt Induces Heme Oxygenase-1 Expression by a Hypoxia-inducible Factor-independent Mechanism in Chinese Hamster Ovary Cells , 2001, The Journal of Biological Chemistry.

[40]  C. Pugh,et al.  Hypoxia and oxidative stress in breast cancer: Hypoxia signalling pathways , 2001, Breast Cancer Research.

[41]  P. Ratcliffe,et al.  Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. , 2001, Blood.

[42]  J. Haddad,et al.  Nuclear Factor-κB Blockade Attenuates but Does Not Abrogate Lipopolysaccharide-Dependent Tumor Necrosis Factor-α Biosynthesis in Alveolar Epithelial Cells , 2001 .

[43]  M. King,et al.  Oxygen Sensing and HIF-1 Activation Does Not Require an Active Mitochondrial Respiratory Chain Electron-transfer Pathway* , 2001, The Journal of Biological Chemistry.

[44]  V. Hudson.  Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. , 2001, Free radical biology & medicine.

[45]  A. de Bruin,et al.  TNF-alpha dependent NF-kappa B activation in cultured canine keratinocytes is partly mediated by reactive oxygen species. , 2001, Veterinary dermatology.

[46]  J. Haddad,et al.  The biphasic immunoregulation of pyrimidylpiperazine (Y‐40138) is IL‐10 sensitive and requires NF‐κB targeting in the alveolar epithelium , 2001, British journal of pharmacology.

[47]  A. Collett,et al.  Oxygen‐evoked Na+ transport in rat fetal distal lung epithelial cells , 2001, The Journal of physiology.

[48]  J. Haddad,et al.  Alpha-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor kappaB translocation and activation: evidence for involvement of an interleukin-1beta193-195 receptor antagonism in the alveolar epithelium. , 2001 .

[49]  A. Collett,et al.  NF-kappaB blockade reduces the O2-evoked rise in Na+ conductance in fetal alveolar cells. , 2001, Biochemical and biophysical research communications.

[50]  J. Bermak,et al.  Evidence for non‐oxidative dopamine cytotoxicity: potent activation of NF‐κ B and lack of protection by anti‐oxidants , 2001, Journal of neurochemistry.

[51]  J. Haddad,et al.  Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium. , 2001, The Journal of pharmacology and experimental therapeutics.

[52]  J. Haddad,et al.  The ex vivo differential expression of apoptosis signaling cofactors in the developing perinatal lung: essential role of oxygenation during the transition from placental to pulmonary-based respiration. , 2001, Biochemical and biophysical research communications.

[53]  B. Brüne,et al.  Accumulation of HIF-1alpha under the influence of nitric oxide. , 2001, Blood.

[54]  J. Yodoi,et al.  An endogenous redox molecule, thioredoxin, regulates transactivation of epidermal growth factor receptor and activation of NF‐κB by lysophosphatidic acid , 2001, FEBS letters.

[55]  J. Haddad,et al.  CHEMIOXYEXCITATION (Δp O2/ROS)-DEPENDENT RELEASE OF IL-1β, IL-6 AND TNF-α: EVIDENCE OF CYTOKINES AS OXYGEN-SENSITIVE MEDIATORS IN THE ALVEOLAR EPITHELIUM , 2001 .

[56]  W. MacNee,et al.  Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? , 2001, Trends in molecular medicine.

[57]  Z. Lee,et al.  Pyrrolidine dithiocarbamate inhibits serum-induced NF-kappaB activation and induces apoptosis in ROS 17/2.8 osteoblasts. , 2001, International immunopharmacology.

[58]  G. Pieper,et al.  Antioxidant treatment inhibits activation of myocardial nuclear factor kappa B and inhibits nitrosylation of myocardial heme protein in cardiac transplant rejection. , 2001, Antioxidants & redox signaling.

[59]  E. Ho,et al.  Dietary Zinc Supplementation Inhibits NFκB Activation and Protects Against Chemically Induced Diabetes in CD1 Mice , 2001, Experimental biology and medicine.

[60]  M. Fujimura,et al.  SOD1 Down-Regulates NF-κB and c-Myc Expression in Mice after Transient Focal Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[61]  L. Deng,et al.  2-Acetylaminofluorene Up-regulates Rat mdr1bExpression through Generating Reactive Oxygen Species That Activate NF-κB Pathway* , 2001, The Journal of Biological Chemistry.

[62]  C. Kretz-remy,et al.  Selenium: A key element that controls NF-κB activation and IκBα half life , 2001 .

[63]  J. Caro,et al.  Hypoxia regulation of gene transcription. , 2001, High altitude medicine & biology.

[64]  S. Gebel,et al.  The activity of NF-kappaB in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke is dependent on thioredoxin. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[65]  R. Johns,et al.  Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. , 2000, Molecular pharmacology.

[66]  J. Hallenbeck,et al.  Tumor Necrosis Factor and Reactive Oxygen Species Cooperative Cytotoxicity Is Mediated via Inhibition of NF-B , 2000 .

[67]  F. Agani,et al.  The Role of Mitochondria in the Regulation of Hypoxia-inducible Factor 1 Expression during Hypoxia* , 2000, The Journal of Biological Chemistry.

[68]  J. Crapo,et al.  Pulmonary immunobiology and inflammation in pulmonary diseases. , 2000, American journal of respiratory and critical care medicine.

[69]  N. Fukuishi,et al.  Xanthine oxidase-derived reactive oxygen species activate nuclear factor kappa B during hepatic ischemia in rats. , 2000, Japanese journal of pharmacology.

[70]  W. MacNee,et al.  Regulation of lipopolysaccharide-mediated interleukin-1beta release by N-acetylcysteine in THP-1 cells. , 2000, The European respiratory journal.

[71]  I. Rahman.  Regulation of nuclear factor-κB, activator protein-1, and glutathione levels by tumor necrosis factor-α and dexamethasone in alveolar epithelial cells , 2000 .

[72]  S. Schoonbroodt,et al.  Oxidative stress interference with the nuclear factor- κB activation pathways , 2000 .

[73]  A. Visvikis,et al.  Gamma-glutamyltranspeptidase-dependent glutathione catabolism results in activation of NF-kB. , 2000, Biochemical and biophysical research communications.

[74]  C. D’Angio,et al.  Oxygen regulation of gene expression: a study in opposites. , 2000, Molecular genetics and metabolism.

[75]  W. MacNee,et al.  Oxidative stress and regulation of glutathione in lung inflammation. , 2000, The European respiratory journal.

[76]  N. Chandel,et al.  Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia , 2000, The Journal of Biological Chemistry.

[77]  J. Haddad,et al.  Immunomodulatory potential of thymulin-Zn(2+) in the alveolar epithelium: amelioration of endotoxin-induced cytokine release and partial amplification of a cytoprotective IL-10-sensitive pathway. , 2000, Biochemical and biophysical research communications.

[78]  M. Matsui,et al.  Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. , 2000, Biochemical and biophysical research communications.

[79]  W. MacNee,et al.  Activation of NF-κB by PM10 Occurs via an Iron-Mediated Mechanism in the Absence of IκB Degradation , 2000 .

[80]  David S. McClintock,et al.  Role of Oxidants in NF-κB Activation and TNF-α Gene Transcription Induced by Hypoxia and Endotoxin1 , 2000, The Journal of Immunology.

[81]  J. Haddad,et al.  Antioxidant/Pro-oxidant Equilibrium Regulates HIF-1α and NF-κB Redox Sensitivity , 2000, The Journal of Biological Chemistry.

[82]  J. Park,et al.  Cadmium blocks hypoxia-inducible factor (HIF)-1-mediated response to hypoxia by stimulating the proteasome-dependent degradation of HIF-1alpha. , 2000, European journal of biochemistry.

[83]  M. Blagosklonny,et al.  Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. , 2000, Cancer research.

[84]  R. Shinkura,et al.  Thioredoxin Inhibits Tumor Necrosis Factor- or Interleukin-1-Induced NF-κB Activation at a Level Upstream of NF-κB-Inducing Kinase , 2000 .

[85]  J. Clemens,et al.  Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. , 2000, Free radical biology & medicine.

[86]  P. Baeuerle,et al.  Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb , 2000 .

[87]  W. MacNee,et al.  Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. , 2000, Free radical biology & medicine.

[88]  J. Haddad,et al.  The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-kappaB (RelA)-selective targeting. , 2000, Biochemical and biophysical research communications.

[89]  J. J. Greene,et al.  Influence of the cellular redox state on NF‐κB‐regulated gene expression , 2000 .

[90]  W. MacNee,et al.  Localization of gamma-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease. , 2000, Free radical biology & medicine.

[91]  L. Poellinger,et al.  A Redox Mechanism Controls Differential DNA Binding Activities of Hypoxia-inducible Factor (HIF) 1α and the HIF-like Factor* , 2000, The Journal of Biological Chemistry.

[92]  E. Ho,et al.  Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes. , 2000, Free radical biology & medicine.

[93]  L. Poellinger,et al.  Redox-Regulated Recruitment of the Transcriptional Coactivators CREB-Binding Protein and SRC-1 to Hypoxia-Inducible Factor 1α , 2000, Molecular and Cellular Biology.

[94]  H. Nakamura,et al.  Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging , 2000, Free radical research.

[95]  J. Christman,et al.  Redox Regulation of Nuclear Factor Kappa B: Therapeutic Potential for Attenuating Inflammatory Responses , 2000, Brain pathology.

[96]  J. Christman,et al.  Oxidative Stress and NF-κB Activation: Correlation in Patients Following Allogeneic Bone Marrow Transplantation , 2000 .

[97]  A. Bowie,et al.  Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.

[98]  R. Vanacore,et al.  Role for copper in transient oxidation and nuclear translocation of MTF-1, but not of NF-kappa B, by the heme-hemopexin transport system. , 2000, Antioxidants & redox signaling.

[99]  J. Haddad,et al.  Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. , 2000, Cytokines, cellular & molecular therapy.

[100]  E. Ho,et al.  Antioxidants, NFκB Activation, and Diabetogenesis , 1999 .

[101]  A. Baba,et al.  Apoptosis in Ca2 +  reperfusion injury of cultured astrocytes: roles of reactive oxygen species and NF‐κB activation , 1999, The European journal of neuroscience.

[102]  G. Semenza,et al.  Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.

[103]  J. Mazière,et al.  Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. , 1999, Biochemical and biophysical research communications.

[104]  H. Wiśniewski,et al.  Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. , 1999, Brain research. Molecular brain research.

[105]  W. MacNee,et al.  Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[106]  Ze'ev Ronai,et al.  Role of redox potential and reactive oxygen species in stress signaling , 1999, Oncogene.

[107]  K. Knudtson,et al.  The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). , 1999, The Journal of biological chemistry.

[108]  B. Huchzermeyer,et al.  Involvement of reactive oxygen species in TNF-α mediated activation of the transcription factor NF-κB in canine dermal fibroblasts , 1999 .

[109]  J. Hayes,et al.  Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. , 1999, Free radical research.

[110]  E. Ho,et al.  Supplementation of N‐acetylcysteine inhibits NFκB activation and protects against alloxan‐induced diabetes in CD‐1 mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  K. Mori,et al.  Distinct Roles of Thioredoxin in the Cytoplasm and in the Nucleus , 1999, The Journal of Biological Chemistry.

[112]  J. Finkelstein,et al.  Antioxidant treatment attenuates cytokine and chemokine levels in murine macrophages following silica exposure. , 1999, Toxicology and applied pharmacology.

[113]  S. Manna,et al.  Overexpression of γ-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1 , 1999, Oncogene.

[114]  J. Caro,et al.  Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins. , 1999, Biochemical and biophysical research communications.

[115]  B. Wallaert,et al.  Thiol regulation of the production of TNF-α, IL-6 and IL-8 by human alveolar macrophages , 1999 .

[116]  D. Gius,et al.  Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. , 1999, Toxicology letters.

[117]  I. Macara,et al.  Cooperativity between Oxidants and Tumor Necrosis Factor in the Activation of Nuclear Factor (NF)- κ B , 1999 .

[118]  Y. Fujii‐Kuriyama,et al.  Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal‐induced interaction with CBP/p300 , 1999, The EMBO journal.

[119]  J. Sweatt,et al.  Mitochondria Mediate Tumor Necrosis Factor-α/NF-κB Signaling in Skeletal Muscle Myotubes , 1999 .

[120]  W. MacNee,et al.  Molecular Mechanism of the Regulation of Glutathione Synthesis by Tumor Necrosis Factor-α and Dexamethasone in Human Alveolar Epithelial Cells* , 1999, The Journal of Biological Chemistry.

[121]  W. MacNee,et al.  Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. , 1999, American journal of respiratory and critical care medicine.

[122]  M. Ueffing,et al.  Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB , 1999, Oncogene.

[123]  Kawashima,et al.  Effects of bucillamine and N‐acetyl‐ L‐cysteine on cytokine production and collagen‐induced arthritis (CIA) , 1999, Clinical and experimental immunology.

[124]  C. Sen,et al.  Nuclear factor kappa B activity in response to oxidants and antioxidants. , 1999, Methods in enzymology.

[125]  C. McClain,et al.  Treatment with glutathione precursor decreases cytokine activity. , 1999, JPEN. Journal of parenteral and enteral nutrition.

[126]  B. Aggarwal,et al.  Antioxidants differentially regulate activation of nuclear factor-kappa B, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis. , 1999, Antioxidants & redox signaling.

[127]  I. Rahman,et al.  Inflammation and the regulation of glutathione level in lung epithelial cells. , 1999, Antioxidants & redox signaling.

[128]  K. Sumikawa,et al.  Glutathione Downregulates the Phosphorylation of IκB: Autoloop Regulation of the NF-κB-Mediated Expression of NF-κB Subunits by TNF-α in Mouse Vascular Endothelial Cells , 1998 .

[129]  K. Roebuck,et al.  H2O2 and Tumor Necrosis Factor-α Induce Differential Binding of the Redox-responsive Transcription Factors AP-1 and NF-κB to the Interleukin-8 Promoter in Endothelial and Epithelial Cells* , 1998, The Journal of Biological Chemistry.

[130]  G. Burckart,et al.  Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target , 1998, Journal of clinical pharmacology.

[131]  T. Kawai,et al.  Glutathione depletion inhibits oxidant-induced activation of nuclear factor-kappa B, AP-1, and c-Jun/ATF-2 in cultured guinea-pig gastric epithelial cells , 1998, Journal of Gastroenterology.

[132]  M. Ginn-Pease,et al.  Redox Signals and NF-κB Activation in T Cells , 1998 .

[133]  J. Caro,et al.  Hypoxia-inducible factor 1alpha (HIF-1alpha) is a non-heme iron protein. Implications for oxygen sensing. , 1998, The Journal of biological chemistry.

[134]  J. Piette,et al.  Impairment of the mitochondrial electron chain transport prevents NF-kappa B activation by hydrogen peroxide. , 1998, Free radical biology & medicine.

[135]  W. MacNee,et al.  Role of transcription factors in inflammatory lung diseases , 1998, Thorax.

[136]  L. Oberley,et al.  Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-κB activation , 1998, Nature Medicine.

[137]  C. Sen.  Redox signaling and the emerging therapeutic potential of thiol antioxidants. , 1998, Biochemical pharmacology.

[138]  G. Stiles,et al.  Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. , 1998, Molecular pharmacology.

[139]  L. Huang,et al.  Erythropoietin: a model system for studying oxygen-dependent gene regulation. , 1998, The Journal of experimental biology.

[140]  P. Ratcliffe,et al.  Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. , 1998, The Journal of experimental biology.

[141]  J. Reimund,et al.  Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis , 1998, European journal of clinical investigation.

[142]  H. Forman,et al.  Transmembrane Redox Signaling Activates NF-κB in Macrophages , 1998 .

[143]  K. Jeang,et al.  Regulatory Role for a Novel Human Thioredoxin Peroxidase in NF-κB Activation* , 1997, The Journal of Biological Chemistry.

[144]  O. Saugstad,et al.  Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD? , 1997, Acta paediatrica.

[145]  R. Brigelius-Flohé,et al.  Thiol modulation inhibits the interleukin (IL)‐1‐mediated activation of an IL‐1 receptor‐associated protein kinase and NF‐xB , 1997, European journal of immunology.

[146]  J. Caro,et al.  Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. , 1997, The Journal of biological chemistry.

[147]  J. Piette,et al.  Involvement of different transduction pathways in NF-kappa B activation by several inducers. , 1997, Free radical research.

[148]  W. MacNee,et al.  Free radical activity of industrial fibers: role of iron in oxidative stress and activation of transcription factors. , 1997, Environmental health perspectives.

[149]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[150]  H. Forman,et al.  Increased transcription of the regulatory subunit of gamma-glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion. , 1997, Archives of biochemistry and biophysics.

[151]  H. Kamata,et al.  Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NF kappa B and AP-1 in human astrocytoma U373 cells. , 1997, Biochemical and biophysical research communications.

[152]  B. Rovin,et al.  Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status. , 1997, Cytokine.

[153]  E. Muñoz,et al.  Cellular redox status influences both cytotoxic and NF‐κB activation in natural killer cells , 1997, Immunology.

[154]  Y. Rojanasakul,et al.  One-Electron Reduction of Chromium(VI) by α-Lipoic Acid and Related Hydroxyl Radical Generation, dG Hydroxylation and Nuclear Transcription Factor-κB Activation , 1997 .

[155]  J. Piette,et al.  Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. , 1997, The Biochemical journal.

[156]  S. Sakurada,et al.  Regulation of NF-kappa B and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation. , 1997, Current topics in cellular regulation.

[157]  K. Schulze-Osthoff,et al.  Oxidative stress and signal transduction. , 1997, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[158]  T. Russo,et al.  Gene regulation by reactive oxygen species. , 1997, Current topics in cellular regulation.

[159]  C. Sen,et al.  Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. , 1997, Advances in pharmacology.

[160]  L. Packer,et al.  Redox regulation of NF-kappa B activation. , 1997, Free radical biology & medicine.

[161]  W. MacNee,et al.  Transcriptional regulation of gamma-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. , 1996, Biochemical and biophysical research communications.

[162]  E. S. Fox,et al.  Thiol regulation of endotoxin-induced release of tumour necrosis factor alpha from isolated rat Kupffer cells. , 1996, The Biochemical journal.

[163]  D. Livingston,et al.  Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit* , 1996, The Journal of Biological Chemistry.

[164]  R. O. Poyton,et al.  Oxygen sensing and molecular adaptation to hypoxia. , 1996, Physiological reviews.

[165]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[166]  J. J. Greene,et al.  Cooperation of protein disulfide isomerase and redox environment in the regulation of NF‐κB and AP1 binding to DNA , 1996, Cell biochemistry and function.

[167]  L. O’Neill,et al.  Inhibition of NF kappa B activity by oxidative processes in intact cells mechanism of action of pyrolidine dithiocarbamate and diamide. , 1996, Biochemical Society transactions.

[168]  Y. Sun,et al.  Redox regulation of transcriptional activators. , 1996, Free radical biology & medicine.

[169]  P. Sigler,et al.  Structure of NF-κB p50 homodimer bound to a κB site , 1998, Nature.

[170]  J. Bonnefoy,et al.  Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis , 1995, The Journal of experimental medicine.

[171]  N. Kaplowitz,et al.  Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. , 1995, Molecular pharmacology.

[172]  K. Schulze-Osthoff,et al.  Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes , 1995 .

[173]  R. Hay,et al.  Regulation of the DNA binding activity of NF-κB , 1995 .

[174]  G. Semenza,et al.  Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1. , 1995, Biochemical and biophysical research communications.

[175]  L. Packer,et al.  Redox regulation of NF-kappa B DNA binding activity by dihydrolipoate. , 1995, Biochemistry and molecular biology international.

[176]  Jeffrey R. Huth,et al.  Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NFκB , 1995 .

[177]  J. Piette,et al.  NF-kappa B transcription factor and human immunodeficiency virus type 1 (HIV-1) activation by methylene blue photosensitization. , 1995, European journal of biochemistry.

[178]  J. Remacle,et al.  Low levels of reactive oxygen species as modulators of cell function. , 1995, Mutation research.

[179]  K. Schulze-Osthoff,et al.  HIV‐1 Tat potentiates TNF‐induced NF‐kappa B activation and cytotoxicity by altering the cellular redox state. , 1995, The EMBO journal.

[180]  Gregory L. Verdine,et al.  Structure of the NF-κB p50 homodimer bound to DNA , 1995, Nature.

[181]  F. Staal,et al.  [17] Redox regulation of activation of NF-κB transcription factor complex: Effects of N-acetylcysteine , 1995 .

[182]  D. Romberger,et al.  Immunological functions of the pulmonary epithelium. , 1995, The European respiratory journal.

[183]  L. Packer,et al.  Redox regulation of DNA-protein interactions by biothiols. , 1995, Methods in enzymology.

[184]  F. Staal,et al.  Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[185]  K. Schulze-Osthoff,et al.  Functions of glutathione and glutathione disulfide in immunology and immunopathology , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[186]  Yamamoto Ken-ichi,et al.  Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro , 1994 .

[187]  H. Pahl,et al.  Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. , 1994, Chemico-biological interactions.

[188]  W. Dröge,et al.  Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. , 1994, European journal of biochemistry.

[189]  P. Baeuerle,et al.  [14] Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB , 1994 .

[190]  Y. Tan,et al.  Differential induction of nuclear NF-kappa B by protein phosphatase inhibitors in primary and transformed human cells. Requirement for both oxidation and phosphorylation in nuclear translocation. , 1993, The Journal of biological chemistry.

[191]  R. Crystal,et al.  Systemic deficiency of glutathione in cystic fibrosis. , 1993, Journal of applied physiology.

[192]  E. Pacht,et al.  Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[193]  L. O’Neill,et al.  Evidence for a redox-sensitive protein tyrosine kinase in nuclear factor kappa B activation and interleukin 2 production in EL4.NOB1 cells. , 1993, Biochemical Society transactions.

[194]  L. Nicod,et al.  Cytokines. 1. Overview. , 1993, Thorax.

[195]  A. Baldwin,et al.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation , 1993, Molecular and cellular biology.

[196]  T. Okamoto,et al.  Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. , 1993, The Journal of biological chemistry.

[197]  Timothy N. C. Wells,et al.  Role of cysteine62 in DNA recognition by the P50 subunit of NF-xB , 1993 .

[198]  B. Aggarwal,et al.  α-Lipoic acid is a potent inhibitor of NF-κB activation in human T cells , 1992 .

[199]  F. Aillet,et al.  Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. , 1992, Journal of immunology.

[200]  J. Yodoi,et al.  Thiordoxin regulates the DNA binding activity of NF-χB by reduction of a disulphid bond involving cysteine 62 , 1992 .

[201]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[202]  G. Bernard,et al.  N-acetylcysteine in experimental and clinical acute lung injury. , 1991, The American journal of medicine.

[203]  W. Leonard,et al.  Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[204]  G. Cohen,et al.  Potentiation of the cell specific toxicity of paraquat by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Implications for the heterogeneous distribution of glutathione (GSH) in rat lung. , 1990, Biochemical pharmacology.

[205]  R. Crystal,et al.  Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.

[206]  O. Aruoma,et al.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. , 1989, Free radical biology & medicine.

[207]  A. Meister.  Glutathione metabolism and its selective modification. , 1988, The Journal of biological chemistry.

[208]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[209]  A. Meister,et al.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.